Compare IVR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVR | CERT |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 740.7M | 860.9M |
| IPO Year | N/A | 2020 |
| Metric | IVR | CERT |
|---|---|---|
| Price | $7.89 | $5.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $8.25 | ★ $11.67 |
| AVG Volume (30 Days) | 2.3M | ★ 3.2M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 17.80% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $150.63 | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | $6.63 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $7.10 | $4.45 |
| 52 Week High | $9.50 | $13.88 |
| Indicator | IVR | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 44.91 |
| Support Level | $7.56 | $5.19 |
| Resistance Level | $7.92 | $6.47 |
| Average True Range (ATR) | 0.15 | 0.35 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 22.22 | 39.65 |
Invesco Mortgage Capital Inc is a REIT that invests, finances, and manages residential and commercial mortgage-backed securities and mortgage loans. The company's portfolio consists of residential mortgage-backed securities (RMBS) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation; Commercial mortgage-backed securities (CMBS) that are not guaranteed by a U.S. government agency or a federally chartered corporation; RMBS that are not guaranteed by a U.S. government agency or a federally chartered corporation; and other real estate-related financing arrangements.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.